Neuroendocrine hyperplasia: Difference between revisions

Content deleted Content added

Inline

Revision as of 06:23, 4 March 2010

Neuroendocrine hyperplasia is a progressive hyperplastic process that ultimately results in obliterative fibrosis of predominantly the pulmonary tree (the lungs). It is characterized by tachypnea, hypoxia, and retractions.^[1] There is no currently recognized treatment for the relentless progression of this disorder.

^ "Neuroendocrine cell hyperplasia of infancy (NCHI)" (HTML). University of Cincinnati College of Medicine. 2006.

This article about a disease, disorder, or medical condition is a stub. You can help Wikipedia by expanding it.

@@ Line 1: / Line 1: @@
 {{Unreferenced stub|auto=yes|date=December 2009}}
 {{Orphan|date=February 2009}}
-'''Neuroendocrine hyperplasia''' is a [[wikt:progressive|progressive]] [[hyperplasia|hyperplastic]] process that ultimately results in [[wikt:obliterate|obliterative]] [[fibrosis]] of predominantly the [[lung|pulmonary]] tree. There is no currently recognized treatment for the relentless progression of this disorder.
+'''Neuroendocrine hyperplasia''' is a [[wikt:progressive|progressive]] [[hyperplasia|hyperplastic]] process that ultimately results in [[wikt:obliterate|obliterative]] [[fibrosis]] of predominantly the [[lung|pulmonary]] tree (the lungs). It is characterized by [[tachypnea]], [[hypoxia]], and [[retractions]].<ref name="Springerlink">{{cite web|url=http://www.springerlink.com/content/pw8x713728772g13/|format=HTML|title=Neuroendocrine cell hyperplasia of infancy (NCHI)|publisher=University of Cincinnati College of Medicine|year=2006}}</ref> There is no currently recognized treatment for the relentless progression of this disorder.
 {{DEFAULTSORT:Neuroendocrine Hyperplasia}}
+==References==
+{{reflist|3}}